Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Adhiyaman V, Vaishnavi A, and Froese A, “Drug Points: Hypersensitivity Reaction to Balsalazide,” BMJ , 2001, 323(7311):489. [PubMed 11532843 ] Connell W and Miller A, “Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy,” Drug Safety , 1999, 21(4):311-23. [PubMed 10514022 ] Diav-Citrin O, Park YH, Veerasuntharam G, et al, “The Safety of Mesalamine in Human Pregnancy: A Prospective Controlled Cohort Study,” Gastroenterology , 1998, 114(1):23-8. [PubMed 9428214 ] Dubinsky M, Abraham B, and Mahadevan U, “Management of the Pregnant IBD Patient,” Inflamm Bowel Dis , 2008, 14(12):1736-50. [PubMed 18626967 ] Kornbluth A and Sachar DB, “Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee,” Am J Gastroenterol , 2010, 105(3):501-23. [PubMed 20068560 ] Lennard L, “Clinical Implications of Thiopurine Methyltransferase - Optimization of Drug Dosage and Potential Drug Interactions,” Ther Drug Monit , 1998, 20(5):527-31. [PubMed 9780130 ] Robertson E, Austin D, Jamieson N, et al, “Balsalazide-Induced Myocarditis,” Int J Cardiol , 2008, 130(3):e121-2. [PubMed 17889383 ] Topic 8713 Version 39.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1004-180.241.123.62-BF10BB01C4-S244013.14]